187 related articles for article (PubMed ID: 38627683)
1. The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder.
Guo J; Zhang T; Chen W; Tan J; Li X; Zheng A; Fu Y; Qiu T
BMC Psychiatry; 2024 Apr; 24(1):285. PubMed ID: 38627683
[TBL] [Abstract][Full Text] [Related]
2. Prospective study on Maresin-1 and cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
Qiu T; Li X; Chen W; He J; Shi L; Zhou C; Zheng A; Lei Z; Tang C; Yu Q; Du L; Guo J
Front Psychiatry; 2023; 14():1132791. PubMed ID: 37009097
[TBL] [Abstract][Full Text] [Related]
3. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
Lee H; Song M; Lee J; Kim JB; Lee MS
J Affect Disord; 2020 Apr; 266():57-62. PubMed ID: 32056928
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].
Xiang JJ; Hong S; Ran LY; Zeng Q; Kong YT; Zhang CY; Liao J; Kuang L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):310-315. PubMed ID: 36949691
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder.
Alcocer-Gómez E; Casas-Barquero N; Williams MR; Romero-Guillena SL; Cañadas-Lozano D; Bullón P; Sánchez-Alcazar JA; Navarro-Pando JM; Cordero MD
Pharmacol Res; 2017 Jul; 121():114-121. PubMed ID: 28465217
[TBL] [Abstract][Full Text] [Related]
6. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
Yin Y; Chen F; Wang W; Wang H; Zhang X
Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.
Alcocer-Gómez E; de Miguel M; Casas-Barquero N; Núñez-Vasco J; Sánchez-Alcazar JA; Fernández-Rodríguez A; Cordero MD
Brain Behav Immun; 2014 Feb; 36():111-7. PubMed ID: 24513871
[TBL] [Abstract][Full Text] [Related]
8. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder.
Jazayeri S; Keshavarz SA; Tehrani-Doost M; Djalali M; Hosseini M; Amini H; Chamari M; Djazayery A
Psychiatry Res; 2010 Jun; 178(1):112-5. PubMed ID: 20466437
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder.
Tian H; Li G; Xu G; Liu J; Wan X; Zhang J; Xie S; Cheng J; Gao S
Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):475-485. PubMed ID: 32361811
[TBL] [Abstract][Full Text] [Related]
10. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
[TBL] [Abstract][Full Text] [Related]
11. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Hannestad J; DellaGioia N; Bloch M
Neuropsychopharmacology; 2011 Nov; 36(12):2452-9. PubMed ID: 21796103
[TBL] [Abstract][Full Text] [Related]
12. Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder.
Liu L; Yang X; Yang C; Tian Y; Li W; Xia L; Liu H
J Affect Disord; 2024 Apr; 350():110-117. PubMed ID: 38220096
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the Levels of Growth Factors in Adolescents with Major Depressive Disorder: A Longitudinal Study during the Treatment with Fluoxetine.
Becerril-Villanueva E; Pérez-Sánchez G; Alvarez-Herrera S; Girón-Pérez MI; Arreola R; Cruz-Fuentes C; Palacios L; de la Peña FR; Pavón L
Mediators Inflamm; 2019; 2019():9130868. PubMed ID: 31827384
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder.
Kok Kendirlioglu B; Unalan Ozpercin P; Yuksel Oksuz O; Sozen S; Cihnioglu R; Kalelioglu T; Ilnem MC; Karamustafalioglu N
Nord J Psychiatry; 2020 Feb; 74(2):83-88. PubMed ID: 31575320
[No Abstract] [Full Text] [Related]
15. Inflammatory Profiles in Depressed Adolescents Treated with Fluoxetine: An 8-Week Follow-up Open Study.
Pérez-Sánchez G; Becerril-Villanueva E; Arreola R; Martínez-Levy G; Hernández-Gutiérrez ME; Velasco-Velásquez MA; Alvarez-Herrera S; Cruz-Fuentes C; Palacios L; de la Peña F; Pavón L
Mediators Inflamm; 2018; 2018():4074051. PubMed ID: 30662368
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder.
Kouba BR; Gil-Mohapel J; S Rodrigues AL
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613574
[TBL] [Abstract][Full Text] [Related]
17. Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats.
Pan Y; Chen XY; Zhang QY; Kong LD
Brain Behav Immun; 2014 Oct; 41():90-100. PubMed ID: 24859041
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
[TBL] [Abstract][Full Text] [Related]
19. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment.
Song C; Halbreich U; Han C; Leonard BE; Luo H
Pharmacopsychiatry; 2009 Sep; 42(5):182-8. PubMed ID: 19724980
[TBL] [Abstract][Full Text] [Related]
20. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
